Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 216

    1.

    Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring.

    Rose C, Bröcker EB, Zillikens D.

    J Dtsch Dermatol Ges. 2009 Oct 28. [Epub ahead of print]PMID: 19878401 [PubMed - as supplied by publisher]Related articles

    2.

    Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.

    Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E.

    Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]PMID: 19874345 [PubMed - as supplied by publisher]Related articles

    3.

    Subcorneal pustular dermatosis-type IgA pemphigus with autoantibodies to desmocollins 1, 2, and 3.

    Düker I, Schaller J, Rose C, Zillikens D, Hashimoto T, Kunze J.

    Arch Dermatol. 2009 Oct;145(10):1159-62.PMID: 19841404 [PubMed - indexed for MEDLINE]Related articles

    4.

    Response to Imatinib Mesylate Depends on the Presence of the V559A-Mutated KIT Oncogene.

    Terheyden P, Houben R, Pajouh P, Thorns C, Zillikens D, Becker JC.

    J Invest Dermatol. 2009 Oct 8. [Epub ahead of print] No abstract available. PMID: 19812602 [PubMed - as supplied by publisher]Related articles

    5.

    Rituximab in severe pemphigus.

    Schmidt E, Goebeler M, Zillikens D.

    Ann N Y Acad Sci. 2009 Sep;1173:683-91. Review.PMID: 19758216 [PubMed - indexed for MEDLINE]Related articles

    6.

    Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

    Probst C, Schlumberger W, Stöcker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L.

    Clin Chim Acta. 2009 Dec;410(1-2):13-8. Epub 2009 Sep 6.PMID: 19737550 [PubMed - in process]Related articles

    7.

    Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis.

    Dörner T, Isenberg D, Jayne D, Wiendl H, Zillikens D, Burmester G; International Roundtable on B cells as Therapeutic Target for Intervention.

    Autoimmun Rev. 2009 Dec;9(2):82-9. Epub 2009 Aug 27.PMID: 19716441 [PubMed - in process]Related articles

    8.

    Animal models for autoimmune bullous dermatoses.

    Bieber K, Sun S, Ishii N, Kasperkiewicz M, Schmidt E, Hirose M, Westermann J, Yu X, Zillikens D, Ludwig RJ.

    Exp Dermatol. 2009 Aug 21. [Epub ahead of print]PMID: 19702839 [PubMed - as supplied by publisher]Related articles

    9.

    Histopathology of anti-laminin 5 mucous membrane pemphigoid.

    Rose C, Schmidt E, Kerstan A, Thoma-Uszynski S, Wesselmann U, Käsbohrer U, Zillikens D, Shimanovich I.

    J Am Acad Dermatol. 2009 Sep;61(3):433-40.PMID: 19700013 [PubMed - indexed for MEDLINE]Related articles

    10.

    Use of high-dose immunoglobulins in dermatology.

    Enk A, Fierlbeck G, French L, Hertl M, Messer G, Meurer M, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D.

    J Dtsch Dermatol Ges. 2009 Sep;7(9):806-812. English, German. PMID: 19624804 [PubMed - in process]Related articles

    11.

    Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.

    Recke A, Rose C, Schmidt E, Bröcker EB, Zillikens D, Sitaru C.

    J Am Acad Dermatol. 2009 Aug;61(2):333-6. Review.PMID: 19615544 [PubMed - indexed for MEDLINE]Related articles

    12.

    High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases.

    Ishii N, Hashimoto T, Zillikens D, Ludwig RJ.

    Clin Rev Allergy Immunol. 2009 Jun 27. [Epub ahead of print]PMID: 19557317 [PubMed - as supplied by publisher]Related articles

    13.

    Subacute cutaneous lupus erythematosus associated with terbinafine.

    Kasperkiewicz M, Anemüller W, Angelova-Fischer I, Rose C, Zillikens D, Fischer TW.

    Clin Exp Dermatol. 2009 Oct;34(7):e403-4. Epub 2009 Jun 22. No abstract available. PMID: 19549237 [PubMed - in process]Related articles

    14.

    Immunogenicity of rituximab in patients with severe pemphigus.

    Schmidt E, Hennig K, Mengede C, Zillikens D, Kromminga A.

    Clin Immunol. 2009 Sep;132(3):334-41. Epub 2009 Jun 7.PMID: 19502112 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Two faces of Janus : Coexistence of systemic lupus erythematosus and psoriasis in the same patient.]

    Shimanovich I, Merl V, Zillikens D, Grabbe J, Rose C.

    Hautarzt. 2009 May 7. [Epub ahead of print] German. PMID: 19418031 [PubMed - as supplied by publisher]Related articles

    16.

    Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid.

    Hofmann SC, Kautz O, Hertl M, Sticherling M, Zillikens D, Bruckner-Tuderman L.

    J Dtsch Dermatol Ges. 2009 Mar;7(3):227-33. English, German. PMID: 19371245 [PubMed - indexed for MEDLINE]Related articles

    17.

    Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.

    Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I.

    J Am Acad Dermatol. 2009 Jul;61(1):39-43. Epub 2009 Apr 2.PMID: 19344979 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diagnosis of autoimmune bullous skin diseases.

    Zillikens D.

    Clin Lab. 2008;54(11-12):491-503. Review.PMID: 19216255 [PubMed - indexed for MEDLINE]Related articles

    19.

    Anti-laminin gamma-1 pemphigoid.

    Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T.

    Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2800-5. Epub 2009 Feb 5.PMID: 19196964 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Research in practice: diagnosis of subepidermal autoimmune bullous disorders.

    Schmidt E, Zillikens D.

    J Dtsch Dermatol Ges. 2009 Apr;7(4):296-300. Epub 2009 Jan 22. Review. English, German. PMID: 19192160 [PubMed - indexed for MEDLINE]Related articles

    21.

    Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.

    Bertram F, Bröcker EB, Zillikens D, Schmidt E.

    J Dtsch Dermatol Ges. 2009 May;7(5):434-40. Epub 2009 Jan 19. English, German. PMID: 19170813 [PubMed - indexed for MEDLINE]Related articles

    22.

    In vivo confocal laser scanning microscopy for non-invasive diagnosis of pemphigus foliaceus.

    Angelova-Fischer I, Pfeuti T, Zillikens D, Rose C.

    Skin Res Technol. 2009 Feb;15(1):40-4.PMID: 19152577 [PubMed - indexed for MEDLINE]Related articles

    23.

    Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

    Liu Z, Sui W, Zhao M, Li Z, Li N, Thresher R, Giudice GJ, Fairley JA, Sitaru C, Zillikens D, Ning G, Marinkovich MP, Diaz LA.

    J Autoimmun. 2008 Dec;31(4):331-8. Epub 2008 Oct 14.PMID: 18922680 [PubMed - indexed for MEDLINE]Related articles

    24.

    Cicatrising conjunctivitis with anti-basement membrane autoantibodies in ectodermal dysplasia.

    Saw VP, Dart JK, Sitaru C, Zillikens D.

    Br J Ophthalmol. 2008 Oct;92(10):1403-10. Review.PMID: 18815422 [PubMed - indexed for MEDLINE]Related articles

    25.

    IgE autoantibodies against the intracellular domain of BP180.

    Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF.

    Br J Dermatol. 2009 Feb;160(2):429-32. Epub 2008 Sep 19.PMID: 18808416 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.

    Heupel WM, Zillikens D, Drenckhahn D, Waschke J.

    J Immunol. 2008 Aug 1;181(3):1825-34.PMID: 18641320 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.

    Sesarman A, Sitaru AG, Olaru F, Zillikens D, Sitaru C.

    J Mol Med. 2008 Aug;86(8):951-9. Epub 2008 Jun 10.PMID: 18542899 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Mucous membrane pemphigoid with ocular involvement. Part II: therapy]

    Meyer-ter-Vehn T, Schmidt E, Zillikens D, Geerling G.

    Ophthalmologe. 2008 Apr;105(4):405-19. Review. German. PMID: 18392628 [PubMed - indexed for MEDLINE]Related articles

    29.

    Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.

    Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, Bystryn JC, Cianchini G, Diaz L, Fivenson D, Hall R, Harman KE, Hashimoto T, Hertl M, Hunzelmann N, Iranzo P, Joly P, Jonkman MF, Kitajima Y, Korman NJ, Martin LK, Mimouni D, Pandya AG, Payne AS, Rubenstein D, Shimizu H, Sinha AA, Sirois D, Zillikens D, Werth VP.

    J Am Acad Dermatol. 2008 Jun;58(6):1043-6. Epub 2008 Mar 14.PMID: 18339444 [PubMed - indexed for MEDLINE]Related articles

    30.

    [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis]

    Schmidt E, Meyer-Ter-Vehn T, Zillikens D, Geerling G.

    Ophthalmologe. 2008 Mar;105(3):285-97; quiz 298. Review. German. PMID: 18335223 [PubMed - indexed for MEDLINE]Related articles

    31.

    Necrobiosis lipoidica in monozygotic twins.

    Shimanovich I, Erdmann H, Grabbe J, Zillikens D, Rose C.

    Arch Dermatol. 2008 Jan;144(1):119-20. No abstract available. PMID: 18209185 [PubMed - indexed for MEDLINE]Related articles

    32.

    Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.

    Sesarman A, Mihai S, Chiriac MT, Olaru F, Sitaru AG, Thurman JM, Zillikens D, Sitaru C.

    Br J Dermatol. 2008 Mar;158(3):463-71. Epub 2008 Jan 17.PMID: 18205879 [PubMed - indexed for MEDLINE]Related articles

    33.

    Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.

    Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S.

    J Dtsch Dermatol Ges. 2008 May;6(5):366-73. Epub 2008 Jan 14. English, German. PMID: 18201220 [PubMed - indexed for MEDLINE]Related articles

    34.

    The pathophysiology of bullous pemphigoid.

    Kasperkiewicz M, Zillikens D.

    Clin Rev Allergy Immunol. 2007 Oct;33(1-2):67-77. Review.PMID: 18094948 [PubMed - indexed for MEDLINE]Related articles

    35.

    A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA.

    Arch Dermatol. 2007 Dec;143(12):1536-42.PMID: 18087004 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.

    Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D.

    Br J Dermatol. 2008 Feb;158(2):382-8. Epub 2007 Dec 6.PMID: 18070210 [PubMed - indexed for MEDLINE]Related articles

    37.

    IgG4 autoantibodies induce dermal-epidermal separation.

    Mihai S, Chiriac MT, Herrero-González JE, Goodall M, Jefferis R, Savage CO, Zillikens D, Sitaru C.

    J Cell Mol Med. 2007 Sep-Oct;11(5):1117-28.PMID: 17979887 [PubMed - indexed for MEDLINE]Related articles

    38.

    Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases.

    Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, Hofmann SC, Karlhofer F, Kautz O, Nitschke M, Opitz A, Quist S, Rose C, Schanz S, Schmidt E, Shimanovich I, Michael M, Ziller F.

    J Dtsch Dermatol Ges. 2007 Oct;5(10):881-7. English, German. PMID: 17910670 [PubMed - indexed for MEDLINE]Related articles

    39.

    Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.

    Sitaru C, Dähnrich C, Probst C, Komorowski L, Blöcker I, Schmidt E, Schlumberger W, Rose C, Stöcker W, Zillikens D.

    Exp Dermatol. 2007 Sep;16(9):770-7.PMID: 17697150 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.

    Spindler V, Drenckhahn D, Zillikens D, Waschke J.

    Am J Pathol. 2007 Sep;171(3):906-16. Epub 2007 Jul 19.PMID: 17640963 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.

    Mihai S, Chiriac MT, Takahashi K, Thurman JM, Holers VM, Zillikens D, Botto M, Sitaru C.

    J Immunol. 2007 May 15;178(10):6514-21.PMID: 17475881 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Erythema and blistering of the left leg. Fixed drug eruption (FDE).

    Shimanovich I, Rose C, Zillikens D, Grabbe J.

    Arch Dermatol. 2007 Apr;143(4):535-40. No abstract available. PMID: 17438190 [PubMed - indexed for MEDLINE]Related articles

    43.

    Histopathology of anti-p200 pemphigoid.

    Rose C, Weyers W, Denisjuk N, Hillen U, Zillikens D, Shimanovich I.

    Am J Dermatopathol. 2007 Apr;29(2):119-24.PMID: 17414431 [PubMed - indexed for MEDLINE]Related articles

    44.

    NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage.

    Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C.

    J Pathol. 2007 May;212(1):56-65.PMID: 17380558 [PubMed - indexed for MEDLINE]Related articles

    45.

    The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.

    Sitaru C, Mihai S, Zillikens D.

    Arch Dermatol Res. 2007 Apr;299(1):1-8. Epub 2007 Feb 3. Review.PMID: 17277959 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    [Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases]

    Kasperkiewicz M, Zillikens D.

    Hautarzt. 2007 Feb;58(2):115-6, 118-21. Review. German. PMID: 17237928 [PubMed - indexed for MEDLINE]Related articles

    47.

    Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.

    Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I.

    J Dermatol. 2007 Jan;34(1):1-8. Review.PMID: 17204094 [PubMed - indexed for MEDLINE]Related articles

    48.

    IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.

    Kopp T, Sitaru C, Pieczkowski F, Schneeberger A, Födinger D, Zillikens D, Stingl G, Karlhofer FM.

    J Dtsch Dermatol Ges. 2006 Dec;4(12):1045-50. English, German. PMID: 17176412 [PubMed - indexed for MEDLINE]Related articles

    49.

    Wolfgang Bargmann-Preis 2006. Pemphigus foliaceus igG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.

    Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D.

    Ann Anat. 2006 Nov;188(6):501-2. No abstract available. PMID: 17140142 [PubMed]Related articles

    50.

    Inhibition of Rho A activity causes pemphigus skin blistering.

    Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D.

    J Cell Biol. 2006 Dec 4;175(5):721-7. Epub 2006 Nov 27.PMID: 17130286 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...